← Scroll for more →
Financial Statements — CRBG
Balance Sheet
(in billions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 0.36 | 0.38 | 0.45 | 0.32 | 0.30 | 0.40 | 0.82 | 0.55 | 0.65 | 0.43 | 0.63 | 0.58 | 0.79 | 0.52 | 0.63 | 0.44 | 0.60 |
| Total Assets | 415.79 | 407.06 | 413.55 | 411.29 | 399.16 | 390.02 | 389.40 | 399.42 | 382.49 | 385.59 | 379.27 | 355.59 | 367.47 | 366.69 | 364.22 | 354.60 | 425.43 |
| Long-term Debt | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 7.87 | 7.87 | 0.43 |
| Total Liabilities | 404.42 | 395.52 | 399.59 | 396.97 | 385.99 | 377.19 | 377.07 | 384.98 | 370.68 | 373.20 | 366.64 | 346.34 | 356.00 | 354.23 | 350.00 | 346.20 | 396.36 |
| Retained Earnings | 18.08 | 18.20 | 18.37 | 17.68 | 17.67 | 18.46 | 19.26 | 17.22 | 18.54 | 18.31 | 17.57 | 19.77 | 17.81 | 17.59 | 18.21 | 16.78 | 10.94 |
| Total Stockholder Equity | 10.65 | 10.81 | 13.20 | 13.54 | 12.30 | 11.98 | 11.46 | 13.61 | 11.00 | 11.58 | 11.77 | 8.37 | 10.56 | 11.56 | 9.38 | 7.53 | 27.23 |
← Scroll for more columns →
Income Statement
(in billions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Premiums Earned | 0.54 | 0.39 | 2.57 | 1.94 | 0.46 | 0.89 | 1.14 | 0.62 | 0.55 | 2.30 | 2.44 | 0.70 | 2.44 | 2.11 | 2.05 | 1.31 |
| Net Investment Income | 3.19 | 3.20 | 3.28 | 3.32 | 3.34 | 3.19 | 3.02 | 3.30 | 2.99 | 2.92 | 3.01 | 2.66 | 2.71 | 2.70 | 2.56 | 2.16 |
| Total Revenue | 3.91 | 3.96 | 6.73 | 5.42 | 2.74 | 3.59 | 6.62 | 2.62 | 3.71 | 5.84 | 3.35 | 5.51 | 5.76 | 4.26 | 3.87 | 7.14 |
| Benefits & Claims | 1.12 | 0.97 | 3.14 | 2.59 | 0.98 | 1.46 | 1.63 | 1.15 | 1.05 | 2.81 | 2.89 | 1.10 | 2.88 | 2.50 | 2.58 | 1.81 |
| Total Benefits & Expenses | 3.86 | 3.87 | 5.76 | 5.46 | 3.35 | 4.45 | 3.69 | 4.21 | 3.25 | 4.82 | 5.12 | 3.04 | 4.85 | 4.93 | 4.65 | 4.04 |
| Tax Provision | 0.05 | 0.16 | 0.17 | (0.18) | 0.06 | (0.20) | 0.70 | (0.41) | 0.12 | 0.19 | (0.43) | 0.39 | 0.16 | (0.22) | (0.25) | 0.63 |
| Net Income | 0.00 | (0.05) | 0.81 | 0.14 | (0.66) | (0.66) | 2.17 | (1.18) | 0.37 | 0.88 | (1.31) | 2.10 | 0.77 | (0.46) | (0.57) | 2.35 |
| Diluted EPS | (0.04) | (0.11) | 1.44 | 0.27 | (1.20) | (1.19) | 3.74 | (2.02) | 0.59 | 1.41 | (2.05) | 3.28 | 1.18 | (0.70) | (0.91) | 3.63 |
← Scroll for more columns →
Cash Flow Statement
(in billions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | (0.04) | (0.01) | 1.88 | 0.02 | (0.26) | 0.38 | 1.48 | 0.08 | (0.01) | 0.60 | 0.77 | 1.02 | 1.27 | 0.30 | 0.49 | 2.20 |
| Investing Cash Flow | 1.57 | (2.53) | (3.47) | (3.32) | (2.67) | (3.87) | (1.35) | (6.22) | (1.32) | (2.64) | (2.21) | (2.38) | 0.59 | (1.48) | (3.92) | (3.33) |
| Financing Cash Flow | (1.54) | 2.47 | 1.72 | 3.32 | 2.83 | 3.07 | 0.15 | 6.03 | 1.56 | 1.84 | 1.45 | 1.19 | (1.59) | 1.07 | 3.62 | 0.98 |
← Scroll for more columns →
Dividends Per Share
(USD)| Metric | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividends Per Share | 0.25 | 0.25 | 0.24 | 0.24 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 |
← Scroll for more columns →